Safety and efficacy of topical formulations containing 0.5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study

被引：19
|
作者：
Masur, C. [1 ]
Soeberdt, M. [1 ]
Kilic, A. [1 ]
Knie, U. [1 ]
Abels, C. [1 ]
机构：
[1] Dr August Wolff GmbH & Co KG Arzneimittel, Bielefeld, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2020年 / 182卷 / 01期
关键词：
D O I：
10.1111/bjd.18234
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：229 / 231
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, double-blind, placebo-controlled trial
    Goldberg, AC
    Sapre, A
    Liu, J
    Capece, R
    Mitchel, YB
    MAYO CLINIC PROCEEDINGS, 2004, 79 (05) : 620 - 629
  • [22] A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF IPRATROPIUM BROMIDE NASAL SPRAY VERSUS PLACEBO IN PATIENTS WITH THE COMMON COLD
    DOCKHORN, R
    GROSSMAN, J
    POSNER, M
    ZINNY, M
    TINKLEMAN, D
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (06) : 1076 - 1082
  • [23] Efficacy and Safety of Oxybutynin Topical Gel 3% in Patients With Urgency and/or Mixed Urinary Incontinence: A Randomized, Double-Blind, Placebo-Controlled Study
    Goldfischer, Evan R.
    Sand, Peter K.
    Thomas, Heather
    Peters-Gee, Jill
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 (01) : 37 - 43
  • [24] Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study
    Inoue, Yuichi
    Hirata, Koichi
    Kuroda, Kenji
    Fujita, Masahiko
    Shimizu, Tetsuo
    Emura, Narutsugu
    Uchimura, Naohisa
    Kagimura, Tatsuo
    Sha, Koji
    Nozawa, Taneyoshi
    SLEEP MEDICINE, 2010, 11 (01) : 11 - 16
  • [25] Efficacy and Safety Results from a randomized controlled Phase-3a Trial of 1% Glycopyrronium Bromide Cream for the Treatment of primary axillary Hyperhidrosis
    Abels, Christoph
    Soeberdt, Michael
    Kilic, Ana
    Reich, Hubert
    Knie, Ulrich
    Masur, Clarissa
    Szeimies, Rolf-Markus
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 8 - 9
  • [26] Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study
    Pablo Castanedo-Cazares, Juan
    Larraga-Pinones, Gabryela
    Ehnis-Perez, Adriana
    Fuentes-Ahumada, Cornelia
    Oros-Ovalle, Cuauhtemoc
    Smoller, Bruce R.
    Torres-Alvarez, Bertha
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 29 - 36
  • [27] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [28] SAFETY AND EFFICACY OF KARXT IN PATIENTS WITH SCHIZOPHRENIA IN THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EMERGENT TRIALS
    Kramer, Kenneth
    Brannan, Stephen K.
    Sauder, Colin
    Kaul, Inder
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i162 - i162
  • [29] Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial
    Seol-Hee, Baek
    Je-Young, Shin
    Sung-Yeon, Sohn
    Kee, Hong Park
    Jun-Soon, Kim
    Bongjae, Kim
    So, Hyun Ahn
    Kyomin, Choi
    Yoon-Ho, Hong
    Sung, Jung-Joon
    PARKINSONISM & RELATED DISORDERS, 2022, 103 : 1 - 6
  • [30] A Randomized, Double-Blind, Placebo-Controlled Study of Erenumab Safety in Patients with Stable Angina
    Depre, C.
    Antalik, L.
    Starling, A. J.
    Koren, M.
    Eisele, O.
    Mikol, D.
    HEADACHE, 2018, 58 : 177 - 177
12345